Hardy Zhou

Cooley advised SoftEye, a San Diego-based company developing specialized chips, cameras, software and algorithms for use in smart glasses, on its sale to TDK Corporation, a Tokyo-based global leader in advanced electronic solutions designed for a smarter, more connected world.

Cooley advised CVP NLH Advisors Limited, an investment firm focused on global blockchain assets, on the closing of its $115 million second crypto fund, CVP NoLimit Fund II.

Cooley advised Scribble Ventures, an early-stage venture firm that invests in pre-seed artificial intelligence (AI) companies, on the close of its $80 million third fund.

Cooley advised VISEN Pharmaceuticals, a late-stage, near-commercialization biopharmaceutical company focused on providing treatments for select endocrine diseases in Greater China (including Hong Kong, Macau and Taiwan), on its HK$783 million (approximately US$101 million) initial public offering (IPO) on the Stock Exchange of Hong Kong, subject to the exercise of a 15% overallotment option.